Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • jazz
    Member
    • Nov 2008
    • 28

    SA tag in SAM file for chimeric reads

    Hi,
    I am using BWA-mem for split read alignment for my single end genomic DNA-seq from Illumina. I know that BWA uses SA tag for marking chimeric reads. When I manually BLAST individual reads with the SA tag I can clearly verify that they are indeed chimeras. However, I could not find details about the SA tag itself. What information is encoded in the SA field? I am posting an example of a chimeric read that maps to two separate genomic locations within the same contig (scf7180000067989)


    HWI-ST387:139:C03WJABXX:5:2108:15315:193815 16 scf7180000067989 85156 60 60M41S * 0 0 TTGAAGTCAAGAAAGTGGTAAAGAGAGATTAATAGGGGTATCTCAGCTACAACAAATATTATATTAAATTAAATGGTTAATCTTGCTTTGCTCACCATAAA * NM:i:2 MD:Z:31G1C26 AS:i:50 XS:i:0 SA:Z:scf7180000067989,85273,-,54S47M,60,1;

    HWI-ST387:139:C03WJABXX:5:2108:15315:193815 272 scf7180000067989 85273 60 54H47M * 0 0 AATATTATATTAAATTAAATGGTTAATCTTGCTTTGCTCACCATAAA * NM:i:1 MD:Z:11T35 AS:i:42 XS:i:22 SA:Z:scf7180000067989,85156,-,60M41S,60,2;

    I am expecting a lot of genome rearrangements in the sample, so ultimately I want to isolate these reads that map to variant locations and identify the regions of microhomology, which could help identify the breakpoint. I am new to Bioinformatics so any inputs would be great.

    Thanks in advance!
  • dcameron
    Member
    • Mar 2013
    • 27

    #2
    It is defined in the SAM tags specifications document which was split out from the main SAM specs at the end of last year.

    Note that bwa can write split alignments in which chimeric segments overlap (eg: alignments of 60M40S, and 50S50M for the same read)

    >I am expecting a lot of genome rearrangements in the sample, so ultimately I want to isolate these reads that map to variant locations and identify the regions of microhomology, which could help identify the breakpoint. I am new to Bioinformatics so any inputs would be great.

    I would recommend using one of the many (50+ at my last count) structural variant callers available that are designed to identify breakpoints. In terms of bwa SA tags, LUMPY is a caller that combines the bwa split read aligments with read pair and coverage information for breakpoint calling. If you're not happy to let the caller perform it's own split read analysis, then I would recommend GRIDSS (disclaimer: my caller) due to the lower false discovery rater compared to other callers. Other callers performing decently in my benchmarking results are manta, CREST and DELLY (with Pindel quite good if your focus is sensitivity).
    Last edited by dcameron; 10-30-2016, 08:33 PM.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    21 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    211 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    78 views
    0 reactions
    Last Post SEQadmin2  
    Working...